TOP STORIES

• BUSINESS MSD Japan’s Sales Surge 7.5% in 2021, 1.5% Growth If Lagevrio Excluded: President
  April 22, 2022

• BUSINESS GSK Japan Chief Has High Hopes for Shingrix, Blenrep, RSV Jab as Future Growth Drivers
  April 21, 2022

• BUSINESS Lumakras, Bimzelx, Pivlaz Now Available in Japan
  April 21, 2022

• BUSINESS Post-Azilva, Takeda Set to Morph into Rare Disease Specialty Pharma in Japan
  April 20, 2022

• REGULATORY SCARDA Chief Sees First 5 Years as Critical, Japan-Made mRNA Jabs as Initial Work
  April 19, 2022

• REGULATORY Japan Approves Novavax’s COVID-19 Vaccine; Distribution to Start in Late May
  April 19, 2022

• REGULATORY Novavax COVID-19 Vaccine Clears MHLW Panel, Approval Expected Soon
  April 19, 2022

• COMMENTARY Ukraine War Sheds Light on Vulnerabilities in Pharmaceutical Supply Chains in Emergencies
  April 19, 2022

• REGULATORY Emergency Approval Plan Clears Lower House Panel; Opposition Bills Rejected, but Some Ideas Make It into Resolution
  April 18, 2022

• BUSINESS Bayer Yakuhin Sees 2021 Sales Skid 0.6% but Still Reach Target, Retains Spot in Top 10
  April 15, 2022

• BUSINESS Lumakras Nears Japan Market, Amgen Eyes Simultaneous Launch with US for Next 5 Oncology Drugs: EVP
  April 14, 2022

• REGULATORY Chuikyo OKs Listing of 8 Drugs on April 20; Vyvgart, Lumakras, and More
  April 13, 2022

• REGULATORY Vyvgart, Pivlaz to Be 1st to Face Zero Premium Rule for Low Cost Disclosures
  April 12, 2022

• REGULATORY Japan Cancels Purchase of 40 Million AstraZeneca Shots: Official
  April 12, 2022

• BUSINESS Astellas, GSK, 2 Other Firms Log 10%-Plus Drop in Workforce: Jiho Poll
  April 11, 2022

• REGULATORY MHLW Set to Boost Recognition of Reporting System for Improper Drug Promotions
  April 8, 2022

• BUSINESS New Grad Hiring Down 4.4% in Spring 2022, Downtrend for Sales Reps Continues: Poll
  April 7, 2022

• BUSINESS Jardiance Now Allowed for Use in HFpEF Patients: Label Update
  April 7, 2022

• BUSINESS Jardiance, Ofev Drive Up Boehringer’s Japan Sales in 2021
  April 6, 2022

• BUSINESS Pfizer Tops 2021 Global Pharma Ranking on Vaccine Boon: Jiho Tally
  April 6, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 69
• 70
• 71
• 72
• 73
• 74
• 75
• 76
• 77
• …
• Next ›
• 最終 »